CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,856 | -36.3% | 45,626 | -15.0% | 0.00% | – |
| Q2 2023 | $92,370 | +7.2% | 53,705 | -5.9% | 0.00% | – |
| Q1 2023 | $86,152 | -7.6% | 57,055 | -2.0% | 0.00% | – |
| Q4 2022 | $93,194 | +5.9% | 58,247 | -5.0% | 0.00% | – |
| Q3 2022 | $88,000 | -79.5% | 61,320 | -74.0% | 0.00% | -100.0% |
| Q2 2022 | $429,000 | +89.0% | 235,470 | +175.8% | 0.00% | – |
| Q1 2022 | $227,000 | -60.0% | 85,379 | -34.9% | 0.00% | -100.0% |
| Q4 2021 | $567,000 | -33.0% | 131,051 | -21.2% | 0.00% | 0.0% |
| Q3 2021 | $846,000 | -20.6% | 166,410 | -1.2% | 0.00% | -50.0% |
| Q2 2021 | $1,065,000 | -24.8% | 168,463 | -8.7% | 0.00% | -33.3% |
| Q1 2021 | $1,416,000 | -5.3% | 184,508 | -19.2% | 0.00% | 0.0% |
| Q4 2020 | $1,496,000 | -53.8% | 228,242 | -53.2% | 0.00% | -57.1% |
| Q3 2020 | $3,241,000 | +278.2% | 487,670 | +372.6% | 0.01% | +250.0% |
| Q2 2020 | $857,000 | +19.4% | 103,180 | +9.8% | 0.00% | 0.0% |
| Q1 2020 | $718,000 | +97.8% | 93,978 | +114.1% | 0.00% | +100.0% |
| Q4 2019 | $363,000 | -22.3% | 43,894 | +73.9% | 0.00% | 0.0% |
| Q3 2018 | $467,000 | -83.9% | 25,248 | -80.1% | 0.00% | -83.3% |
| Q2 2018 | $2,899,000 | -46.7% | 126,819 | -33.7% | 0.01% | -33.3% |
| Q1 2018 | $5,439,000 | +128.7% | 191,201 | +77.4% | 0.01% | +125.0% |
| Q4 2017 | $2,378,000 | +746.3% | 107,753 | +597.5% | 0.00% | – |
| Q3 2017 | $281,000 | -18.1% | 15,448 | -30.2% | 0.00% | -100.0% |
| Q2 2017 | $343,000 | -9.0% | 22,134 | +1.3% | 0.00% | 0.0% |
| Q1 2017 | $377,000 | +55.1% | 21,842 | 0.0% | 0.00% | – |
| Q4 2016 | $243,000 | – | 21,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |